$0.27
+0.04 (+15.46%)
Open$0.24
Previous Close$0.24
Day High$0.33
Day Low$0.23
52W High$13.80
52W Low$0.18
Volume—
Avg Volume19.65M
Market Cap7.50M
P/E Ratio—
EPS$-9.85
SectorBiotechnology
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 3.42M | 3.23M | 3.00M |
| Net Income | -386,907 | -351,594 | -373,147 |
| Profit Margin | -11.3% | -10.9% | -12.5% |
| EBITDA | -622,705 | -634,407 | -526,103 |
| Free Cash Flow | -366,603 | -274,517 | -229,625 |
| Rev Growth | +21.7% | +15.6% | +5.5% |
| Debt/Equity | 0.38 | 0.31 | 0.42 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |